Sale of 4,345 shares at $11.8903 per share.
Reporting Person Powl Brian T. · Officer Title Chief Commercial Officer · Transaction Code S
Traded Aug 21, 2026 · Disclosed Aug 24, 2026
Source: SEC Form 4 · 0001193125-26-363810 · filed 2026-08-24 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Kura Oncology, Inc. (KURA)." Disclosed 2026-08-24. https://desqlong.com/cards/0001193125-26-363810-1 (retrieved 2026-09-26).